Wicki Andreas's Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Dec 14, 2022
- Accession no.
- 0001104659-22-127089
- Filed
- Dec 14, 2022
- Trade date
- Dec 12-14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.74M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wicki AndreasCIK 0001511472 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2022 | Common Stock | SSaleDisposed | −22,391 | $60.36 | −$1,351,520.76 | 2,154,393 | Indirect | |
| Dec 13, 2022 | Common Stock | SSaleDisposed | −6,320 | $60.13 | −$380,021.6 | 2,148,073 | Indirect | |
| Dec 14, 2022 | Common Stock | SSaleDisposed | −130 | $60.00 | −$7,800 | 2,147,943 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.